Bosh sahifa950210 ā¢ KRX
add
Prestige Biopharma Ltd
Yopilish kursi
11Ā 450,00Ā ā©
Kunlik diapazon
11Ā 300,00Ā ā© - 11Ā 880,00Ā ā©
Yillik diapazon
10Ā 550,00Ā ā© - 20Ā 000,00Ā ā©
Bozor kapitalizatsiyasi
706,73Ā mlrd KRW
OŹ»rtacha hajm
151,46Ā ming
Narx/foyda
43,46
Dividend daromadliligi
-
Bozor yangiliklari
MarketWatch
1 kun oldin
The S&P 500 is undergoing a historic shift that could reshape the stock market
0,69%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,31Ā mlrd | 3,87% |
Joriy xarajat | 24,39Ā mlrd | 94,85% |
Sof foyda | -12,34Ā mlrd | -112,87% |
Sof foyda marjasi | -534,55 | -104,94% |
Har bir ulushga tushum | ā | ā |
EBITDA | -18,82Ā mlrd | -64,52% |
Amaldagi soliq stavkasi | 0,34% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 134,81Ā mlrd | -40,29% |
Jami aktivlari | 714,76Ā mlrd | -0,26% |
Jami passivlari | 215,44Ā mlrd | -5,55% |
Umumiy kapital | 499,31Ā mlrd | ā |
Tarqatilgan aksiyalar | 60,17Ā mln | ā |
Narxi/balansdagi bahosi | 1,69 | ā |
Aktivlardan daromad | -8,31% | ā |
Kapitaldan daromad | -9,49% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -12,34Ā mlrd | -112,87% |
Operatsiyalardan naqd pul | -13,13Ā mlrd | 36,66% |
Sarmoyadan naqd pul | 15,37Ā mlrd | 142,72% |
Moliyadan naqd pul | -21,76Ā mlrd | -209,61% |
Naqd pulning sof oŹ»zgarishi | -20,35Ā mlrd | 43,75% |
BoŹ»sh pul | -24,71Ā mlrd | -176,94% |
Haqida
Tashkil etilgan
2015
Xodimlar soni
54
